iShares MSCI Brazil ETF USD Acc | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (14)

Latest Posts

About This Stock More About This Stock
3 Biotech Stocks Wall Street Predicts Will Rally By 45% Or More
Article By: StockNews
Sunday, May 30, 2021 11:20 AM EDT
Wall Street analysts expect the biotech industry to grow significantly soon, with the biotech stocks Organogenesis (ORGO​​​​​​​), BioDelivery Sciences (BDSI) and Champions Oncology (CSBR) gaining more than 45% in the near term.
In this article: BDSI, CSBR, ORGO Also: PBE, SPY
Read
US Stock Market Weekly Update December 2 - 6
Article By: Stavros Georgiadis
Saturday, December 7, 2019 7:43 PM EDT
A better than expected jobs report released on Friday was enough to send stocks higher at the close of the trading week. Economic fundamentals in the absence of rumors and statements about the US-China trade deal moved financial markets.
In this article: THOR, VIST, AKER, CSBR, NLTX
Read
Wall Street Bulls To Flourish In Q4: 5 Solid Growth Picks
Article By: Zacks Investment Research
Tuesday, October 2, 2018 11:46 PM EDT
The Wall Street bull-run, which entered its longest ever expansionary phase on Aug 22, is showing no signs of abatement. Despite trade war concerns, a robust U.S. economy and strong earnings results boosted investors’ confidence in the stock markets.
In this article: MED, GFN, TLYS, AFI, CSBR
Read
Best ETFs & Stocks From The Top Sector Of Q3
Article By: Sweta Killa
Monday, October 1, 2018 11:11 PM EDT
Healthcare was the best-performing sector of the third quarter, jumping 14.1% — its highest quarterly gain since the first quarter of 2013.
In this article: ENDP, FXH, IHF, IYH, IRMD, RARX, IDXG, ARKG, CSBR, XLV
Read
5 Best Biotech Stocks To Buy In October
Article By: Zacks Investment Research
Monday, October 1, 2018 11:50 AM EDT
Here are five stocks that are expected to move north following successful drug developments.
In this article: CSBR, CYDY, INFI, NKTR, ZTS Also: AMRN, ACAD, SRPT, GILD, AGN
Read

Latest Tweets for $CSBR

No tweets yet!

PARTNER HEADLINES